| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |